Clinique Saint Exupery
- Address
- 29 Rue Emile Lecrivain, 31400 Toulouse, France
Clinique Saint Exupery - Rheumatology & Vascular Inflammation Research
Clinique Saint Exupery is a specialized medical research center with expertise in rheumatologic and vascular inflammatory conditions. The center focuses on advancing therapeutic strategies for complex autoimmune disorders, with particular emphasis on optimizing treatment protocols and medication management approaches.
- Giant Cell Arteritis management and tocilizumab therapy optimization
- Biologic medication discontinuation strategies in inflammatory vasculitis
- Long-term relapse prevention in autoimmune vascular diseases
The research team is actively investigating treatment de-escalation protocols to determine the most effective methods for discontinuing biologic therapies while minimizing relapse risk. Their current work examines comparative approaches for tocilizumab withdrawal in patients with Giant Cell Arteritis, aiming to establish evidence-based guidelines for medication tapering that balance disease control with long-term safety considerations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinique Saint Exupery
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Efficacy and Safety of Transitioning to KPL-387 Monotherapy in Participants with Well-Controlled Recurrent Pericarditis | Kiniksa Pharmaceuticals GmbH | Phase II | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Prednisone | 4 | Unknown | 2018-02-02 | 2026-06-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.